4//SEC Filing
Cytosorbents Corp 4
Accession 0001144204-15-022332
$CTSOCIK 0001175151operating
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 8:11 PM ET
Size
7.9 KB
Accession
0001144204-15-022332
Insider Transaction Report
Form 4
BARTLETT ROBERT HAWES
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2015-04-08+20,000→ 20,000 totalExercise: $8.07Exp: 2020-04-08→ Common Stock (20,000 underlying) - Award
Common Stock
2015-04-08+30,000→ 30,000 total
Footnotes (2)
- [F1]These shares represent restricted stock units and will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan.
- [F2]Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, 45% of which vest upon achieving 2015 budgeted revenues and not exceeding budgeted operating expenses; 30% of which vest upon achievement of multiple clinical trial objectives in calendar year 2015, as determined in the discretion of the Board of Directors; 15% of which vests upon demonstration of reasonable progress in the U.S. regulatory approval of one of CytoSorbents Corporation's products, as determined in the discretion of the Board of Directors; and 10% of which vests upon achievement of one or more new major strategic partnerships, as determined in the discretion of the Board of Directors.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175151
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 8:11 PM ET
- Size
- 7.9 KB